Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
11/2005
11/29/2005CA2355493C Therapeutic compositions comprising excess enantiomer
11/29/2005CA2332513C New derivatives of 4-sulfonamide piperidine, preparation process thereof and the pharmaceutical compositions they contain
11/29/2005CA2288445C 5-oxo-pyrrolidine-2-carboxylic acid hydroxamide derivatives
11/29/2005CA2123048C Tetrazole derivatives of bile acids, processes for their preparation and the use of these compounds as medicaments
11/24/2005WO2005111027A1 Novel method of synthesising 1,3,4,5-tetrahydro-2h-3-benzazepin-2-one derivatives and use thereof in the synthesis of ivabradine and the salts thereof for addition to a pharmaceutically acceptable acid
11/24/2005WO2005111021A1 Preparation of candesartan cilexetil in high purity
11/24/2005WO2005110993A1 Novel method of synthesising ivabradine and the salts thereof for addition to a pharmaceutically acceptable acid
11/24/2005WO2005110480A2 Combination of organic compounds
11/24/2005WO2005110393A1 Essential fatty acids in the prevention and/or treatment of depression in patients with coronary heart or artery disease
11/24/2005WO2005110383A1 The use of kauranes compounds in the manufacture of medicament
11/24/2005WO2004092379A9 Method for treatment of angiogenic disorders
11/24/2005US20050261756 Coated stent
11/24/2005US20050261502 2-Amino-4-(1,3-benzodioxol-5-yl)-6-benzyloxy-3,5-pyridinedicarbonitrile, acting as adenosine-receptor-selective ligands, for the prophylaxis and/or treatment of cardiovascular disorders
11/24/2005US20050261472 Binding moieties for fibrin
11/24/2005US20050261376 reduction of 4,5-dimethoxy-1-cyano-benzocyclobutane, resolution with optically active diacid (N-acetyl-L-glutamic acid), amidification and reduction; improved yield and optical purity; chemical intermediates; antiischemic agents
11/24/2005US20050261361 Novel crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other forms
11/24/2005US20050261360 Dissolving the crystalline form in acetone, allowing to convert to amorphous form and then precipitating it out
11/24/2005US20050261359 Novel processes for preparing amorphous atorvastatin hemi-calcium
11/24/2005US20050261355 Carvedilol hydobromide
11/24/2005US20050261349 Medicine for prevention or treatment of diabetes
11/24/2005US20050261343 Anthranilamides and their use as pharmaceutical agents
11/24/2005US20050261335 Carvedilol formulations
11/24/2005US20050261323 Medical uses of novel carbamate-substituted pyrazolopyridine derivatives
11/24/2005US20050261317 Inhibitors of human phosphatidylinositol 3-kinase delta
11/24/2005US20050261313 For angiogenesis mediated diseases; cancer; acylation, cyclization and Heck-type reduction
11/24/2005US20050261305 Cyclic protein tyrosine kinase inhibitors
11/24/2005US20050261300 Liquid pharmaceutical formulations containing 3.7-diazabicyclo[3,3,1]nonane compounds and methods of treatment relating to arrhythmic events
11/24/2005US20050261293 Compounds which inhibit leukocyte adhesion mediated by VLA-4
11/24/2005US20050261283 Methods and compositions for the treatment of graft failure
11/24/2005US20050261281 Pharmaceutical compounds
11/24/2005US20050261277 Pentacyclic oxepines and derivatives thereof, compositions and methods
11/24/2005US20050261269 New derivatives of amidines, their preparation, their use as medicaments and the pharmaceutical compositions containing them
11/24/2005US20050261248 New-4-pyrrolopyrimidin-6-YL)benzenesulphonamide derivatives
11/24/2005US20050261199 Amidated D-Proline, D-Tyrosine, D-Valine, and D-Leucine, D-Threonine, D-Valline; lowering serum triglyceride levels
11/24/2005US20050261192 Novel polypeptide and its DNA
11/24/2005US20050261187 Methods and compositions relating to MEK5 and cardiac hypertrophy and dilated cardiomyopathy
11/24/2005US20050261186 NRG-2 nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods
11/24/2005US20050261182 Treatment of neurological dysfunction comprising fructopyranose sulfamates and erythropoietin
11/24/2005US20050261179 Vasoregulating compounds and methods of their use
11/24/2005US20050261169 Peptide and peptide mimetic derivatives having integrin inhibitor properties III
11/24/2005US20050261163 Pharmaceutical products, preparation and uses thereof
11/24/2005US20050260747 Embryonic stem cells and neural progenitor cells derived therefrom
11/24/2005US20050260731 Lipoprotein associated phospholipase A2, inhibitors thereof and use of the same in diagnosis and therapy
11/24/2005US20050260601 Recombinant mutants of rhabdovirus and methods of use thereof
11/24/2005US20050260575 Method for identifying substances useful for treating inflammation using the response element to the ikbalpha ror receptor
11/24/2005US20050260192 Leukocyte function associated antigens comprising integrin I-domain for use in identifying modulators for prevention and treatment of inflammatory disorders; immunosuppressive agents
11/24/2005US20050260174 Systems and methods for treating patients with processed lipoaspirate cells
11/24/2005US20050260124 Method of diagnosing risk of myocardial infarction
11/24/2005DE102004019413A1 Use of substances (e.g. nucleic acids, proteins and peptides), which restrain/reduce the expression and/or activity of protein kinase C-epsilon for the treatment/prevention of e.g. circulatory and vascular diseases
11/24/2005CA2606472A1 The use of kauranes compounds in the manufacture of medicament
11/24/2005CA2567166A1 Medicaments containing n-sulfamoyl-n'-arylpiperazines for the prophylaxis or treatment of obesity and related conditions
11/24/2005CA2566257A1 Genetic polymorphisms associated with vascular diseases, methods of detection and uses thereof
11/24/2005CA2562597A1 Preparation of candesartan cilexetil in high purity
11/24/2005CA2561717A1 Combination of organic compounds
11/24/2005CA2508065A1 Antiproliferative drug and delivery device
11/24/2005CA2507712A1 Pharmaceutical compounds
11/24/2005CA2507710A1 Tricyclic pyrazole derivatives and their use as cb1 or cb2 modulators
11/23/2005EP1598349A1 Novel 2-pyridinecarboxamide derivatives
11/23/2005EP1598346A1 Process for producing acid adduct salt of polyacidic base compound
11/23/2005EP1598340A1 1-(4-piperidinyl)-1,3-dihydro-2h-benzoxazole-2-one derivatives and related compounds as nociceptin analogs and orl1 ligands for the treatment of pain
11/23/2005EP1598339A1 1-(4-amino-cyclohexyl)-1,3-dihydro-2h-benzimidazole-2-one derivatives and related compounds as nociceptin analogs and orl1 ligands for the treatment of pain
11/23/2005EP1598338A1 1-(4-piperidinyl)-1,3-dihydro-2h-indole-2-one derivatives and related compounds as nociceptin analogs and orl1 ligands for the treatment of pain
11/23/2005EP1598334A1 Thyroid hormone analogues and methods for their preparation
11/23/2005EP1598333A1 Process for the preparation of (1S)-4,5-dimethoxy-1-(methylaminomethyl)-benzocyclobutane, acid addition salts thereof and its use for the synthesis of ivabradine and for its pharmaceutically acceptable acid addition salts
11/23/2005EP1598077A1 Use of the neurotoxic component of botulinum toxins for the treatment of a spastic muscle
11/23/2005EP1598076A1 Interleukin 6 production inhibitor
11/23/2005EP1598072A1 Medical drug containing fine particle of noble metal
11/23/2005EP1598070A1 Administration of enoxaparin sodium to patients 75 years and older with ST-segment elevation myocardial infarction
11/23/2005EP1597587A2 Diagnostics and therapeutics for diseases associated with g-protein coupled receptor hm74a (hm74a)
11/23/2005EP1596885A2 Uses of anti-insulin-like growth factor i receptor antibodies
11/23/2005EP1596868A1 Method for treating severe heart failure and medicament therefor
11/23/2005EP1596861A1 Pharmaceutical combinations comprising a nos inhibitor and an nmda receptor antagonist
11/23/2005EP1596856A2 Drugs containing substituted 2-aryl-aminoacetic acid compounds and/or substituted 2-heteroaryl-aminoacetic acid compounds
11/23/2005EP1596850A1 Use of 2,5-dihydroxybenzenesulfonic compounds for the treatment of disorders based on an impairment of no production and/or of regulation of edhf function
11/23/2005EP1596670A2 Oils enriched with diacylglycerols and phytosterol esters for use in the reduction of cholesterol and triglycerides
11/23/2005EP1446015A4 Remodeling of tissues and organs
11/23/2005EP1390055B1 Tripeptide derivatives for the treatment of postlesional diseases of the nervous system
11/23/2005EP1377550B9 Phenyl heterocyclyl ether derivatives as serotonin re-uptake inhibitors
11/23/2005EP1280777B1 Tetrahydroisoquinoline analogs useful as growth hormone secretagogues
11/23/2005EP1200831B1 Modulating binding site on potassium channels used for screening
11/23/2005EP0837939B1 Mammalian apoptosis inhibitor protein gene family, primers, probes and detection methods
11/23/2005CN1701061A New compounds for the inhibition of rotamases and use thereof
11/23/2005CN1700934A Liquid aerosol formulations and aerosol generating devices and methods for generating aerosols
11/23/2005CN1700924A Hypotensive agent and method for producing the same
11/23/2005CN1700922A 3, 10, and 12a substituted tetracycline compounds
11/23/2005CN1700920A Phophylactic and therapeutic use of hydroxysteroids
11/23/2005CN1700919A Method for treating severe heart failure and medicament therefor
11/23/2005CN1700916A Use of HIV-protease inhibitors to block cell migration and/or invasion, tissue inflitration and oedema formation
11/23/2005CN1700912A Choline ascorbate formulations
11/23/2005CN1699410A Apolipoprotein A-1 agonists and their use to treat dyslipidemic disorders
11/23/2005CN1699331A Process for the synthesis of (is)-4,5-dimethoxy-1-(methylaminomethyl)-benzocyclobutane and uses thereof
11/23/2005CN1698603A Pharmaceutical composition
11/23/2005CN1698601A Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl iv, processes for their preparation, and their use
11/23/2005CN1228446C Conotoxin MVII A and Trx fusion protein and its expression and application
11/23/2005CN1228335C Crystal choline ascorbate
11/23/2005CN1228082C Method for preparing pharmaceutics of hydrolysate of brain protein
11/23/2005CN1228057C Compound of solanesol and its preparing process
11/23/2005CN1228052C Total flavone for treating cadiovasular cerebrovasular system diseases, and preparing method and use thereof
11/23/2005CN1228051C Medicinal composition for treating cardiovascular disease
11/23/2005CN1228043C Sustained release groundmass for highly soluble drugs
1 ... 740 741 742 743 744 745 746 747 748 749 750 751 752 753 754 755 756 757 758 759 760 ... 1595